Leiden University / LURIS

» Als het gaat om octrooien | 2-02-10 Dik van Harte

8-5-2012 / Leiden

Leiden University / LURIS

Commercialisation Clinic: The world of patents

“Patents:

protection of innovative behaviour,

source of inspiring information”

» Als het gaat om octrooien | 2-02-10 2

publ. +

right

Patent- application

(XX)

<> 18 mnth

20 yrs

12 mnth

PCT (WO)

18 mnth > 21 mnth

(administrative)

publ.

20 yrs

right

publ.

Procedures

18-36 mnth

publ.

20 yrs

right

National

18 mnth

EP

publ.

20 yrs

right

» Als het gaat om octrooien | 2-02-10

IP rights When/Why to use ? How to use ? Where to find ? How to search ?


Check patentability

File patent application

inspiration, IPC classes, technical solutions (how?), market information ( who?),

strategic information (license <=> own development)

patent search

market introduction

product

prototype

concept

idea


Zoeken op: naam (aanvrager/uitvinder) nummer (publicatie)

Zoeken op: onderwerp (trefwoorden)

ECLA: G07C5/00T Communicating informations regard- ing the working of vehicles etc., to a remotely located station B64C13/24 Initiating flying-control surfaces, lift- increasing flaps, air brakes etc, using radiated signals B64D45/00H Protecting aircraft against criminal attack G08B13/196 Activation of burglar, theft or intruder alarms using television cameras

IPC: G06F7/00 Digital data processing depending on content of handled data

Zoeken op: onderwerp (zoekcodes)

3354 hits 918 hits 777 hits 3915 hits


Octrooipublicaties stamcellen

haematopoietic embryonicmesenchymal nervesfats endothelialmuscles hepatocyticepithelial pancreatictumours/cancers osteoblastic/osteocyticchondrocytic

Stamcellen

Stamcellijnen

SC's bij trans-

plantaten en

prothesen

SC's bij

diagnostica

Bron: EPOQUE (EPO)

A61L27/38B14 (transplants / grafts)

G01N33/50D2F14 (diagnostics)

C12N5/06B* (cells / cell lines)


European Classification (ECLA) codes

A61L27/00 Materials for (coating of) [N: grafts or] prostheses A61L27/36 • containing ingredients of undetermined constitution . . . A61L27/38 • • [N: containing added animal cells] A61L27/38B • • • [N: characterised by specific cells or progenitors thereof . . . A61L27/38B14 • • • • [N: Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells]

Use in transplants/grafts

concerning stem cells

G01N33/00 Investigating or analysing materials by specific methods not covered by the preceding groups G01N33/48 • biological material, e.g. blood, urine G01N33/50 • • Chemical analysis of biological material . . .; Testing involving biospecific ligand binding methods; Immunological testing G01N33/50D • • • [N: involving human or animal cells] G01N33/50D2 • • • • [N: for testing or evaluating the effect of chemical or biological compounds, e.g. drugs . . .] G01N33/50D2F • • • • • [N: involving specific cell types] G01N33/50D2F14 • • • • • • [N: Stem cells]

Use in diagnostics

C12N5/00 Undifferentiated human, animal or plant cells, e.g. cell lines . . . C12N5/06 • Animal cells or tissues; [N: Human cells or tissues] C12N5/06B • • [N: Vertebrate cells] C12N5/06B2(P) • • • [N: Embryonic cells . . .] / [N: Pluripotent cells, e.g. embryonic stem cells] C12N5/06B4(P) • • • [N: Germ cells] / [N: Primordial germ cells, e.g. embryonic germ cells] C12N5/06B6(P) • • • [N: Muscle cells] / [N: Stem cells . . .] C12N5/06B8(P) • • • [N: Cells of the nervous system] / [N: Stem cells . . .] C12N5/06B11(P) • • • [N: Cells from the blood or the immune system] / [N: Haematopoietic stem cells . . .] C12N5/06B12(P) • • • [N: Epithelial cells] / [N: Stem cells . . .] C12N5/06B14(P) • • • [N: Hepatocytes] / [N: Stem cells . . .] C12N5/06B18(P) • • • [N: Osteoblasts; Osteocytes; Odontoblasts] / [N: Stem cells . . .] C12N5/06B20(P) • • • [N: Chondrocytes] / [N: Stem cells . . .] C12N5/06B21(P) • • • [N: Cells from bone marrow stroma] / [N: Mesenchymal stem cells] C12N5/06B22(P) • • • [N: Pancreatic cells] / [N: Stem cells . . .] C12N5/06B26(P) • • • [N: Fat cells, e.g. adipocytes] / [N: Stem cells . . .] C12N5/06B28(P) • • • [N: Endothelial cells] / [N: Stem cells . . .] C12N5/06B30(P) • • • [N: Tumour cells; Cancer cells] / [N: Stem cells . . .]

Stem cells / Stem cell lines


General applicants / inventors / coverage / state-of-the-art http://worldwide.espacenet.com

http://www.google.nl/patents

Status termination / granting / opposition / validity (per country or region) NL http://register.octrooicentrum.nl

EP/ WO http://register.epoline.org Advanced search US http://portal.uspto.gov/pair Public PAIR divers http://www.won-nl.org Links / Publieke data . . .

Codes state-of-the-art ECLA http://worldwide.espacenet.com/eclasrch?&classification=ecla

IPC http://www.ipc-nl.nl http://www.wipo.int/classifications/en


What you always wanted to know . . . 1) What is known anyway in this field (state-of-the-art) ? 2) Where can I find someone with interest in my product (licensors/buyers) ? Who can help me developing my idea to a real product (partners) ? 3) What have these people invented anyway in this field (patent portfolio) ?

Some search examples

1+2+3 http://ep.espacenet.com 3 http://www.won-nl.org / Links – Publieke data


http://worldwide.espacenet.com


http://ep.espacenet.com http://www.won-nl.org


Do’s

• Use *** when searching on keyword(s)

Beginning of term followed by anything

• Always try to find the right ECLA-code(s) a.s.a.p.

Make your search keyword-independant

• Use ECLA-code(s) instead of IPC-code(s)

More detailed = more precise

• Search keyword(s) only in the field “Title or abstract”

Better chance to find something

• Use titles, abstracts and drawings to get a first impression

Reading can be done later


Don’ts

• Don’t search for applications, search for technology

Technological aspects are patented, not the applications

• Don’t forget to first make a list of available information

Be in control of your search

• Don’t focus on general aspects, focus on details

General aspects are well known, so not worth searching for

• Don’t give up too soon

There’s always something worthwhile to be found

• Don’t be happy if you haven’t found anything

There’s always a state-of-the-art on your topic


14

Some practical examples: 1 Lenses with variable focus length (state-of-the-art) 2 Edible vaccines (partners/licensees/buyers) 3 Resuscitation equipment (patent –position– check)


Lenses with variable focus length

Subject:

In order to perform microscopic research in a more

efficient way, I invented a new kind of lens system.

The focus point of my lens can be changed in a con-

tinously variable way. The lens system is filled with

a conducting fluid, which is in contact with two or

more electrodes. By changing the voltage over the

electrodes, I can thus change the focus of my lens

system.

Of course I do realise that this kind of lens can be

used in many applications like spectacles, illumina-

tion, endoscopy, microscopy, photography etc.

Question:

Is this a very original idea, in other words am I the

first one ?

Subquestions:

Where are these kind of lenses classified ? What is

the state-of-the-art ? Who can be my partner/buyer/

licensee/licensor ?


G02B 3/14 2333 hits G02B26/02L 1956 hits

) ) in combination 711 hits: )

US2007211207 Univ. of California

WO2008062067 Varioptic

WO2005003842 Philips Electronics


20



Edible vaccines

Subject:

In some parts of the world a lot of people are

starving, while at the same time these parts are

subject to specific diseases.

My idea is to solve both problems at the same time.

I can achieve that by modifying crops etc. in a way,

that when they grow they will produce medicine.

After harvesting the crops I can produce food of it,

hand it over to the sick and starving people, thus

giving them medicine and food at the same time.

Question:

What parties can we approach for possible coopera-

tion and/or licensing?

Subquestions:

Where are these kind of inventions classified ? Who

are the (main) patent applicants ?


Note: There is even a company called “Edible Vaccines Inc” !!!

192 “different” patent applicants found in 1870 different patent positions

Biggest applicants (top 10): - Large Scale Biology 5,61 % - Dow Agrosciences 4,33 % - Biosource Technology 3,16 % - BASF Plant Science 2,67 % - Medicago 2,62 % - Fraunhofer USA / Scripps Research In- stitute / University of Central Florida 2,51 % - Thompson Boyce Plant Research 2,46 % - Plant Research International 2,41 % - Planet Biotechnology 2,30 % - Chugai Pharmaceutical 2,19 % Other Dutch applicants: - Dienst Landbouwkundig Onderzoek 1,12 % - Rijk Zwaan Zaadteelt & -handel 0,43 % - Wageningen Business Generator 0,16 % - Instituut Dierhouderij Lelystad 0,11 % - Unilever 0,05 %


25



Subject:

I’m doing research on how to assist people with a cardiac

arrest. I want to develop some new equipment in the field

of resuscitation, based on a frequently interrupted

pushing movement on the chest area of a victim/patient.

The other day I received a letter, in which a Mr Lars

Sunnanväder of Jolife AB warned me about the fact that

they had a patent position on this issue.

He told me to better stop my activities, otherwise I

probably would be accused of infringing their patent

rights.

Question:

What is the truth behind all this ?

Subquestions:

Do they have a patent position on this matter ? If so,

what is it ?

Resuscitation equipment

» Als het gaat om octrooien | 2-02-10 SE0100616

US2007276298

ZA200509157 = CN1787796

NO328082

WO2007145562

WO2008066455

WO2008066267

WO2008097153

US2009260637

KR20110014186


Thanks for you attention, and good luck . . .

Dik van Harte [email protected]

088 – 6026659

NL Octrooicentrum www.agentschap.nl/octrooicentrum

088 – 6026900


Let’s give it a try . . .

• Silver catalysts (Geus & de Jong - ZWO)

– about priority filings, patent holders, patent families, state-of-the-art impressions,

granted NL patent rights, and ECLA classification codes . . .

• Osteoarthitis screening methods (Novartis)

– about priority filings, EP patent procedures, granting procedure files, and ECLA

classification codes . . .

• Therapeutic cloning (Whitehead Institute)

– about patent strategy, patent portfolios, and granted NL patent rights . . .

• Animal fodder based on stem cells (---)

– about patent strength, patent validity of rights, and state-of the-art impressions . . .

Leiden University / LURIS

Documents

Transcript of Leiden University / LURIS